Skip to main content

300K Solutions

300K Solutions presents at the Biobanks Workshop in Coimbra, Portugal

300K Solutions will participate in the Workshop on Biobanks, to be held on March 9th, 2026, at the Auditorium I of the Congress Center of Hospitais da Universidade de Coimbra (HUC) in Coimbra, Portugal.

Our Chief Technology Officer Mario Morgado, will deliver the presentation “Stabilization of biological samples at room temperature, the new era of biobanking” at 15:00. This session will showcase how our innovative technology is transforming sample preservation, eliminating the need for cold chain maintenance and opening new possibilities for biobanking operations.

The workshop brings together leading experts from Portuguese and Spanish biobanking networks, including representatives from the National Tumour Biobank Network, the Networked Biobank for Oncological Diseases in Castile and León (BEOCyL), the National DNA Bank Carlos III, and the Biobanco.pt Consortium. It will be an excellent opportunity to connect with the Iberian biobanking community and discuss the future of biological sample management.

We look forward to engaging with the Portuguese biobanking community!

Stay updated on our activities!

One Technology. Infinite Possibilities.

DNA

RNA

PLASMA/ SERUM

BLOOD CELL FRACTION

WHOLE BLOOD

TISSUES

We are opening a collaborative space to explore and discuss potential applications of 300K technology.

Our goal is to foster knowledge exchange between researchers, clinicians and innovators interested in real-world use cases.

CONNECT, EXPLORE, AND EXCHANGE IDEAS ON 300K APPLICATIONS

Share:

More Posts

300K Solutions will be present at EHA2026

Blood-derived sample stabilization is a critical need in hematology and biomarker research. Current preservative-based solutions provide stability for only a few days, while longer storage often requires freezing—an approach that is not always feasible.
300K Solutions leverages freeze-drying technology to extend stability from days to months in blood cells and plasma/serum. This approach preserves sample integrity from collection to analysis, minimizing biomarker degradation and eliminating the need for refrigerated logistics.

Contact Us